Industry

CINCINNATI–(BUSINESS WIRE)–The U. S. Environmental Protection Agency (EPA) has registered Microban 24 Multi-Purpose Cleaner (EPA Reg No. 4091-21-3573) to keep killing 99.9% of bacteria & viruses that cause the flu and COVID-19, for up to 24 hours, even when the surface is touched or contacted multiple times1. While it had previously been registered by the … [Read more…]

NEW HAVEN, Conn.–(BUSINESS WIRE)–Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences: Jefferies Healthcare Conference in New York, NY on Wednesday, June 8, 2022 at 10:30 a.m. ET. JMP … [Read more…]

ST. LOUIS & SAN DIEGO–(BUSINESS WIRE)–Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of off-the-shelf cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced that management will participate in two upcoming investor conferences in June: Jefferies Healthcare Conference Format: Presentation Presentation Date/Time: Wednesday, June 8, 2022 at 4:30 … [Read more…]

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, announced the appointment of Deborah Yount as Chief Human Resources Officer, effective today. Ms. Yount will have responsibility for global Human Resources activities. “We are excited to have … [Read more…]

Trial evaluating AB248, a CD8+ T cell cis-targeted IL-2 immunotherapy, in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, aims to address unmet need for patients who are non-responsive to previous anti-PD-1 therapy or enhance current standard of care in an early line of therapy SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies … [Read more…]

WALTHAM, Mass.–(BUSINESS WIRE)–Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, today announced that Michael Gilman, Ph.D., Chief Executive Officer, will present a corporate overview at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 3:30 p.m. ET in New York. About Arrakis … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–Miroculus, Inc., developer of revolutionary tools for personal lab automation, today announced its partnership with Element Biosciences, Inc., developer of the AVITI System, a new and disruptive DNA sequencing platform launched on March 14th, to demonstrate seamless library preparation compatibility of the Miro Canvas digital microfluidics platform with the AVITI System. As technologies … [Read more…]

– Preclinical data suggest efficacy of new investigational microbial consortium, called DE486, to reduce chemotherapy-induced mucositis inflammation – – A Phase 1b clinical trial to assess whether SER-155 prevents life-threatening complications of stem cell transplant – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, announced the presentation of preclinical data supporting … [Read more…]

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–WellAir, a leading indoor air disinfection and purification solutions provider, today announced that JJ Littrell has been appointed as the Company’s Chief Financial Officer (CFO), effective immediately. Ms. Littrell has been working closely with the chief executive officer, Kari Dixon, as vice president of accounting, driving rigor and lean management across … [Read more…]

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in a fireside chat at the Jefferies Healthcare Conference in New York, NY on Wednesday, June 8, 2022 at 8:00 a.m. … [Read more…]